{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T08:37:46Z","timestamp":1773477466558,"version":"3.50.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1038\/nri1688","type":"journal-article","created":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T15:14:59Z","timestamp":1125587699000},"page":"688-698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":350,"title":["Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation"],"prefix":"10.1038","volume":"5","author":[{"given":"Warren J.","family":"Leonard","sequence":"first","affiliation":[]},{"given":"Rosanne","family":"Spolski","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnri1688_CR1","first-page":"701","volume-title":"Fundamental Immunology","author":"WJ Leonard","year":"2003","unstructured":"Leonard, W. J. in Fundamental Immunology 5th Edn (ed. Paul, W. E.) 701\u2013747 (Lippincott Williams & Wilkins, Philadelphia, 2003)"},{"key":"BFnri1688_CR2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/35105066","volume":"1","author":"WJ Leonard","year":"2001","unstructured":"Leonard, W. J. Cytokines and immunodeficiency diseases. Nature Rev. Immunol. 1, 200\u2013208 (2001).","journal-title":"Nature Rev. Immunol."},{"key":"BFnri1688_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0092-8674(93)90167-O","volume":"73","author":"M Noguchi","year":"1993","unstructured":"Noguchi, M. et al. Interleukin-2 receptor \u03b3 chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147\u2013157 (1993).","journal-title":"Cell"},{"key":"BFnri1688_CR4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.270.5237.797","volume":"270","author":"SM Russell","year":"1995","unstructured":"Russell, S. M. et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270, 797\u2013800 (1995).","journal-title":"Science"},{"key":"BFnri1688_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/377065a0","volume":"377","author":"P Macchi","year":"1995","unstructured":"Macchi, P. et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377, 65\u201368 (1995).","journal-title":"Nature"},{"key":"BFnri1688_CR6","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1073\/pnas.200360997","volume":"97","author":"K Ozaki","year":"2000","unstructured":"Ozaki, K., Kikly, K., Michalovich, D., Young, P. R. & Leonard, W. J. Cloning of a type I cytokine receptor most related to the IL-2 receptor \u03b2 chain. Proc. Natl Acad. Sci. USA 97, 11439\u201311444 (2000). This was the first report to identify the IL-21 receptor as a novel type I cytokine receptor and to describe its structural features and signal-transduction pathways.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1688_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35040504","volume":"408","author":"J Parrish-Novak","year":"2000","unstructured":"Parrish-Novak, J. et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408, 57\u201363 (2000). This paper identifies the IL-21 receptor and its ligand and presents the first analysis of the proliferative and functional effects of IL-21 on T cells, B cells and NK cells.","journal-title":"Nature"},{"key":"BFnri1688_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.167.1.1","volume":"167","author":"H Asao","year":"2001","unstructured":"Asao, H. et al. The common \u03b3-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167, 1\u20135 (2001).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR9","doi-asserted-by":"crossref","first-page":"8725","DOI":"10.1021\/bi0202023","volume":"41","author":"T Habib","year":"2002","unstructured":"Habib, T., Senadheera, S., Weinberg, K. & Kaushansky, K. The common \u03b3 chain (\u03b3c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 41, 8725\u20138731 (2002).","journal-title":"Biochemistry"},{"key":"BFnri1688_CR10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4049\/jimmunol.170.2.711","volume":"170","author":"F Bennett","year":"2003","unstructured":"Bennett, F. et al. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J. Immunol. 170, 711\u2013718 (2003).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR11","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.4049\/jimmunol.169.7.3600","volume":"169","author":"M Strengell","year":"2002","unstructured":"Strengell, M., Sareneva, T., Foster, D., Julkunen, I. & Matikainen, S. IL-21 up-regulates the expression of genes associated with innate immunity and TH1 response. J. Immunol. 169, 3600\u20133605 (2002).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR12","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.4049\/jimmunol.170.11.5464","volume":"170","author":"M Strengell","year":"2003","unstructured":"Strengell, M. et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-\u03b3 production in human NK and T cells. J. Immunol. 170, 5464\u20135469 (2003).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/1074-7613(95)90141-8","volume":"2","author":"J-X Lin","year":"1995","unstructured":"Lin, J. -X. et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2, 331\u2013339 (1995).","journal-title":"Immunity"},{"key":"BFnri1688_CR14","doi-asserted-by":"crossref","first-page":"10738","DOI":"10.1074\/jbc.271.18.10738","volume":"271","author":"J-X Lin","year":"1996","unstructured":"Lin, J. -X., Mietz, J., Modi, W. S., John, S. & Leonard, W. J. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J. Biol. Chem. 271, 10738\u201310744 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnri1688_CR15","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1126\/science.8085155","volume":"265","author":"J Hou","year":"1994","unstructured":"Hou, J. et al. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265, 1701\u20131706 (1994).","journal-title":"Science"},{"key":"BFnri1688_CR16","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/MCB.15.6.3336","volume":"15","author":"FW Quelle","year":"1995","unstructured":"Quelle, F. W. et al. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15, 3336\u20133343 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri1688_CR17","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1002\/eji.1830241225","volume":"24","author":"M Nielsen","year":"1994","unstructured":"Nielsen, M., Svejgaard, A., Skov, S. & Odum, N. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur. J. Immunol. 24, 3082\u20133086 (1994).","journal-title":"Eur. J. Immunol."},{"key":"BFnri1688_CR18","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1128\/MCB.17.9.5328","volume":"17","author":"YE Chin","year":"1997","unstructured":"Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A. & Fu, X. Y. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17, 5328\u20135337 (1997).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri1688_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.0959-9673.2003.00363.x","volume":"84","author":"A Stephanou","year":"2003","unstructured":"Stephanou, A. & Latchman, D. S. STAT-1: a novel regulator of apoptosis. Int. J. Exp. Pathol. 84, 239\u2013244 (2003).","journal-title":"Int. J. Exp. Pathol."},{"key":"BFnri1688_CR20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.7541555","volume":"269","author":"CL Yu","year":"1995","unstructured":"Yu, C. L. et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81\u201383 (1995).","journal-title":"Science"},{"key":"BFnri1688_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","volume":"98","author":"JF Bromberg","year":"1999","unstructured":"Bromberg, J. F. et al. Stat3 as an oncogene. Cell 98, 295\u2013303 (1999).","journal-title":"Cell"},{"key":"BFnri1688_CR22","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/sj.onc.1203476","volume":"19","author":"J Bromberg","year":"2000","unstructured":"Bromberg, J. & Darnell, J. E. Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19, 2468\u20132473 (2000).","journal-title":"Oncogene"},{"key":"BFnri1688_CR23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.173.1.657","volume":"173","author":"H Jin","year":"2004","unstructured":"Jin, H., Carrio, R., Yu, A. & Malek, T. R. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J. Immunol. 173, 657\u2013665 (2004). This paper describes the context-dependent effects of IL-21 on the B-cell lineage and identifies a BIM-dependent, IL-21-mediated apoptotic pathway in T-cell-independent B-cell responses.","journal-title":"J. Immunol."},{"key":"BFnri1688_CR24","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2003-03-0669","volume":"102","author":"K Brandt","year":"2003","unstructured":"Brandt, K., Bulfone-Paus, S., Foster, D. C. & Ruckert, R. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102, 4090\u20134098 (2003).","journal-title":"Blood"},{"key":"BFnri1688_CR25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1046\/j.1523-1747.2003.12603.x","volume":"121","author":"K Brandt","year":"2003","unstructured":"Brandt, K. et al. Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. J. Invest. Dermatol. 121, 1379\u20131382 (2003).","journal-title":"J. Invest. Dermatol."},{"key":"BFnri1688_CR26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/art.20883","volume":"52","author":"JH Distler","year":"2005","unstructured":"Distler, J. H. et al. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum. 52, 856\u2013864 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnri1688_CR27","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","volume":"298","author":"K Ozaki","year":"2002","unstructured":"Ozaki, K. et al. A critical role for IL-21 in regulating immunoglobulin production. Science 298, 1630\u20131634 (2002). This paper describes the defective antibody production in  Il21r\u2212\/\u2212 mice and shows that IL-21 and IL-4 cooperate in the regulation of antibody production.","journal-title":"Science"},{"key":"BFnri1688_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0008-8749(02)00519-1","volume":"218","author":"M Eberl","year":"2002","unstructured":"Eberl, M., Engel, R., Beck, E. & Jomaa, H. Differentiation of human \u03b3\u03b4 T cells towards distinct memory phenotypes. Cell. Immunol. 218, 1\u20136 (2002).","journal-title":"Cell. Immunol."},{"key":"BFnri1688_CR29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1189\/jlb.1003488","volume":"76","author":"M Strengell","year":"2004","unstructured":"Strengell, M., Julkunen, I. & Matikainen, S. IFN-\u03b1 regulates IL-21 and IL-21R expression in human NK and T cells. J. Leukoc. Biol. 76, 416\u2013422 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"BFnri1688_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","volume":"201","author":"R Zeng","year":"2005","unstructured":"Zeng, R. et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med. 201, 139\u2013148 (2005). This report describes the cooperative effect of IL-21 and IL-15 on CD8+ T-cell proliferation and antitumour activity towards established melanomas.","journal-title":"J. Exp. Med."},{"key":"BFnri1688_CR31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4049\/jimmunol.173.1.68","volume":"173","author":"T Chtanova","year":"2004","unstructured":"Chtanova, T. et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-TH1\/TH2 effector cells that provide help for B cells. J. Immunol. 173, 68\u201378 (2004).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1084\/jem.20020620","volume":"196","author":"AL Wurster","year":"2002","unstructured":"Wurster, A. L. et al. Interleukin 21 is a T helper (TH) cell 2 cytokine that specifically inhibits the differentiation of naive TH cells into interferon \u03b3-producing TH1 cells. J. Exp. Med. 196, 969\u2013977 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnri1688_CR33","doi-asserted-by":"crossref","first-page":"25291","DOI":"10.1074\/jbc.M501459200","volume":"280","author":"H-P Kim","year":"2005","unstructured":"Kim, H. -P., Korn, L. L., Gamero, A. M. & Leonard, W. J. Calcium-dependent activation of interleukin-21 gene expression in T cells. J. Biol. Chem. 280, 25291\u201325297 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnri1688_CR34","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1073\/pnas.0409512102","volume":"102","author":"DS Mehta","year":"2005","unstructured":"Mehta, D. S., Wurster, A. L., Weinmann, A. S. & Grusby, M. J. NFATc2 and T-bet contribute to T-helper-cell-subset-specific regulation of IL-21 expression. Proc. Natl Acad. Sci. USA 102, 2016\u20132021 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1688_CR35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1074-7613(02)00295-9","volume":"16","author":"MT Kasaian","year":"2002","unstructured":"Kasaian, M. T. et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16, 559\u2013569 (2002).","journal-title":"Immunity"},{"key":"BFnri1688_CR36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.1948049","volume":"254","author":"R Kuhn","year":"1991","unstructured":"Kuhn, R., Rajewsky, K. & Muller, W. Generation and analysis of interleukin-4 deficient mice. Science 254, 707\u2013710 (1991).","journal-title":"Science"},{"key":"BFnri1688_CR37","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1182\/blood-2002-04-1115","volume":"100","author":"A Suto","year":"2002","unstructured":"Suto, A. et al. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C\u03b5 transcription of IL-4-stimulated B cells. Blood 100, 4565\u20134573 (2002).","journal-title":"Blood"},{"key":"BFnri1688_CR38","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0952-7915(00)00153-9","volume":"12","author":"HC Oettgen","year":"2000","unstructured":"Oettgen, H. C. Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of \u03b5 germline transcripts. Curr. Opin. Immunol. 12, 618\u2013623 (2000).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnri1688_CR39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1074-7613(00)80439-2","volume":"4","author":"MH Kaplan","year":"1996","unstructured":"Kaplan, M. H., Schindler, U., Smiley, S. T. & Grusby, M. J. Stat6 is required for mediating responses to IL-4 and for development of TH2 cells. Immunity 4, 313\u2013319 (1996).","journal-title":"Immunity"},{"key":"BFnri1688_CR40","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1073\/pnas.90.18.8464","volume":"90","author":"X Cao","year":"1993","unstructured":"Cao, X. et al. Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) \u03b3 chain: chromosomal mapping and tissue specificity of IL-2R \u03b3 chain expression. Proc. Natl Acad. Sci. USA 90, 8464\u20138468 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1688_CR41","doi-asserted-by":"crossref","first-page":"9466","DOI":"10.1073\/pnas.91.20.9466","volume":"91","author":"JP DiSanto","year":"1994","unstructured":"DiSanto, J. P., Rieux-Laucat, F., Dautry-Varsat, A., Fischer, A. & de Saint Basile, G. Defective human interleukin 2 receptor \u03b3 chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. Proc. Natl Acad. Sci. USA 91, 9466\u20139470 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1688_CR42","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/3877","volume":"20","author":"A Puel","year":"1998","unstructured":"Puel, A., Ziegler, S. F., Buckley, R. H. & Leonard, W. J. Defective IL7R expression in T\u2212B+NK+ severe combined immunodeficiency. Nature Genet. 20, 394\u2013397 (1998).","journal-title":"Nature Genet."},{"key":"BFnri1688_CR43","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1146\/annurev.bi.58.070189.004303","volume":"58","author":"TA Waldmann","year":"1989","unstructured":"Waldmann, T. A. The multi-subunit interleukin-2 receptor. Annu. Rev. Biochem. 58, 875\u2013911 (1989).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnri1688_CR44","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1073\/pnas.85.9.3090","volume":"85","author":"ME Conley","year":"1988","unstructured":"Conley, M. E. et al. Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc. Natl Acad. Sci. USA 85, 3090\u20133094 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1688_CR45","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0092-8674(00)80291-3","volume":"89","author":"K Akashi","year":"1997","unstructured":"Akashi, K., Kondo, M., von Freeden-Jeffry, U., Murray, R. & Weissman, I. L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89, 1033\u20131041 (1997).","journal-title":"Cell"},{"key":"BFnri1688_CR46","doi-asserted-by":"crossref","first-page":"22733","DOI":"10.1016\/S0021-9258(18)41588-8","volume":"268","author":"H Otani","year":"1993","unstructured":"Otani, H., Erdos, M. & Leonard, W. J. Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line. J. Biol. Chem. 268, 22733\u201322736 (1993).","journal-title":"J. Biol. Chem."},{"key":"BFnri1688_CR47","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.4049\/jimmunol.170.8.4111","volume":"170","author":"DS Mehta","year":"2003","unstructured":"Mehta, D. S. et al. IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 170, 4111\u20134118 (2003).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR48","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","volume":"173","author":"K Ozaki","year":"2004","unstructured":"Ozaki, K. et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173, 5361\u20135371 (2004). This report shows that IL-21 initiates the development of B cells into plasma cells through directly inducing expression of the master regulator of this process, BLIMP1.","journal-title":"J. Immunol."},{"key":"BFnri1688_CR49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.immunol.17.1.221","volume":"17","author":"M Lenardo","year":"1999","unstructured":"Lenardo, M. et al. Mature T lymphocyte apoptosis \u2014 immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221\u2013253 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1688_CR50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1074-7613(00)80566-X","volume":"8","author":"Y Refaeli","year":"1998","unstructured":"Refaeli, Y., Van Parijs, L., London, C. A., Tschopp, J. & Abbas, A. K. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8, 615\u2013623 (1998).","journal-title":"Immunity"},{"key":"BFnri1688_CR51","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.4049\/jimmunol.172.9.5154","volume":"172","author":"J Pene","year":"2004","unstructured":"Pene, J. et al. IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172, 5154\u20135157 (2004).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.immunol.21.120601.141138","volume":"21","author":"KL Calame","year":"2003","unstructured":"Calame, K. L., Lin, K. I. & Tunyaplin, C. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21, 205\u2013230 (2003).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1688_CR53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","volume":"17","author":"AL Shaffer","year":"2002","unstructured":"Shaffer, A. L. et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17, 51\u201362 (2002).","journal-title":"Immunity"},{"key":"BFnri1688_CR54","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/art.1780221105","volume":"22","author":"ED Murphy","year":"1979","unstructured":"Murphy, E. D. & Roths, J. B. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22, 1188\u20131194 (1979).","journal-title":"Arthritis Rheum."},{"key":"BFnri1688_CR55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/1074-7613(95)90047-0","volume":"2","author":"X Cao","year":"1995","unstructured":"Cao, X. et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor \u03b3 chain. Immunity 2, 223\u2013238 (1995).","journal-title":"Immunity"},{"key":"BFnri1688_CR56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1073\/pnas.92.2.377","volume":"92","author":"JP DiSanto","year":"1995","unstructured":"DiSanto, J. P., Muller, W., Guy-Grand, D., Fischer, A. & Rajewsky, K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor \u03b3 chain. Proc. Natl Acad. Sci. USA 92, 377\u2013381 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1688_CR57","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1126\/science.7770771","volume":"268","author":"H Suzuki","year":"1995","unstructured":"Suzuki, H. et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor \u03b2. Science 268, 1472\u20131476 (1995).","journal-title":"Science"},{"key":"BFnri1688_CR58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","volume":"9","author":"JP Lodolce","year":"1998","unstructured":"Lodolce, J. P. et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669\u2013676 (1998).","journal-title":"Immunity"},{"key":"BFnri1688_CR59","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","volume":"191","author":"MK Kennedy","year":"2000","unstructured":"Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771\u2013780 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnri1688_CR60","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/eji.200324533","volume":"33","author":"S Sivori","year":"2003","unstructured":"Sivori, S. et al. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur. J. Immunol. 33, 3439\u20133447 (2003).","journal-title":"Eur. J. Immunol."},{"key":"BFnri1688_CR61","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1073\/pnas.072065999","volume":"99","author":"S Sivori","year":"2002","unstructured":"Sivori, S. et al. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl Acad. Sci. USA 99, 4526\u20134531 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1688_CR62","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4049\/jimmunol.174.3.1213","volume":"174","author":"CA Vosshenrich","year":"2005","unstructured":"Vosshenrich, C. A. et al. Roles for common cytokine receptor \u03b3-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J. Immunol. 174, 1213\u20131221 (2005).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.0303097","volume":"74","author":"JA Toomey","year":"2003","unstructured":"Toomey, J. A., Gays, F., Foster, D. & Brooks, C. G. Cytokine requirements for the growth and development of mouse NK cells in vitro. J. Leukoc. Biol. 74, 233\u2013242 (2003).","journal-title":"J. Leukoc. Biol."},{"key":"BFnri1688_CR64","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.4049\/jimmunol.172.4.2048","volume":"172","author":"J Brady","year":"2004","unstructured":"Brady, J., Hayakawa, Y., Smyth, M. J. & Nutt, S. L. IL-21 induces the functional maturation of murine NK cells. J. Immunol. 172, 2048\u20132058 (2004).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR65","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/80868","volume":"1","author":"KS Schluns","year":"2000","unstructured":"Schluns, K. S., Kieper, W. C., Jameson, S. C. & Lefrancois, L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nature Immunol. 1, 426\u2013432 (2000).","journal-title":"Nature Immunol."},{"key":"BFnri1688_CR66","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1074-7613(00)80564-6","volume":"8","author":"X Zhang","year":"1998","unstructured":"Zhang, X., Sun, S., Hwang, I., Tough, D. F. & Sprent, J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8, 591\u2013599 (1998).","journal-title":"Immunity"},{"key":"BFnri1688_CR67","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(00)80550-6","volume":"8","author":"F Andrade","year":"1998","unstructured":"Andrade, F. et al. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 8, 451\u2013460 (1998).","journal-title":"Immunity"},{"key":"BFnri1688_CR68","first-page":"9016","volume":"63","author":"G Wang","year":"2003","unstructured":"Wang, G. et al. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res. 63, 9016\u20139022 (2003).","journal-title":"Cancer Res."},{"key":"BFnri1688_CR69","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.4049\/jimmunol.173.12.7521","volume":"173","author":"M Pelletier","year":"2004","unstructured":"Pelletier, M., Bouchard, A. & Girard, D. In vivo and in vitro roles of IL-21 in inflammation. J. Immunol. 173, 7521\u20137530 (2004).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR70","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","volume":"23","author":"MS Anderson","year":"2005","unstructured":"Anderson, M. S. & Bluestone, J. A. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23, 447\u2013485 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1688_CR71","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2337\/diab.46.4.695","volume":"46","author":"P Denny","year":"1997","unstructured":"Denny, P. et al. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes 46, 695\u2013700 (1997).","journal-title":"Diabetes"},{"key":"BFnri1688_CR72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(04)00335-6","volume":"117","author":"C King","year":"2004","unstructured":"King, C., Ilic, A., Koelsch, K. & Sarvetnick, N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117, 265\u2013277 (2004).","journal-title":"Cell"},{"key":"BFnri1688_CR73","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.4049\/jimmunol.174.5.2696","volume":"174","author":"TL Vollmer","year":"2005","unstructured":"Vollmer, T. L. et al. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J. Immunol. 174, 2696\u20132701 (2005).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR74","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","volume":"198","author":"WW Overwijk","year":"2003","unstructured":"Overwijk, W. W. et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J. Exp. Med. 198, 569\u2013580 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnri1688_CR75","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1073\/pnas.0307298101","volume":"101","author":"CA Klebanoff","year":"2004","unstructured":"Klebanoff, C. A. et al. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc. Natl Acad. Sci. USA 101, 1969\u20131974 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1688_CR76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.cgt.7700552","volume":"10","author":"S Ugai","year":"2003","unstructured":"Ugai, S. et al. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts. Cancer Gene Ther. 10, 187\u2013192 (2003).","journal-title":"Cancer Gene Ther."},{"key":"BFnri1688_CR77","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.cgt.7700630","volume":"10","author":"S Ugai","year":"2003","unstructured":"Ugai, S. et al. Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects. Cancer Gene Ther. 10, 771\u2013778 (2003).","journal-title":"Cancer Gene Ther."},{"key":"BFnri1688_CR78","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4049\/jimmunol.171.2.608","volume":"171","author":"HL Ma","year":"2003","unstructured":"Ma, H. L. et al. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-\u03b3. J. Immunol. 171, 608\u2013615 (2003).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR79","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4049\/jimmunol.172.3.1540","volume":"172","author":"E Di Carlo","year":"2004","unstructured":"Di Carlo, E. et al. IL-21 induces tumor rejection by specific CTL and IFN-\u03b3-dependent CXC chemokines in syngeneic mice. J. Immunol. 172, 1540\u20131547 (2004).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR80","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4049\/jimmunol.173.2.900","volume":"173","author":"A Moroz","year":"2004","unstructured":"Moroz, A. et al. IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J. Immunol. 173, 900\u2013909 (2004). This paper describes the unique ability of IL-21 to induce long-term immunity to tumours through its anti-apoptotic and survival effects on CD8+ T cells.","journal-title":"J. Immunol."},{"key":"BFnri1688_CR81","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.4049\/jimmunol.169.4.1753","volume":"169","author":"P Shrikant","year":"2002","unstructured":"Shrikant, P. & Mescher, M. F. Opposing effects of IL-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis. J. Immunol. 169, 1753\u20131759 (2002).","journal-title":"J. Immunol."},{"key":"BFnri1688_CR82","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1525-0016(03)00222-3","volume":"8","author":"T Kishida","year":"2003","unstructured":"Kishida, T. et al. Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol. Ther. 8, 552\u2013558 (2003).","journal-title":"Mol. Ther."},{"key":"BFnri1688_CR83","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/352621a0","volume":"352","author":"H Schorle","year":"1991","unstructured":"Schorle, H. et al. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621\u2013624 (1991).","journal-title":"Nature"},{"key":"BFnri1688_CR84","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.8235625","volume":"262","author":"TM Kundig","year":"1993","unstructured":"Kundig, T. M. et al. Immune responses in interleukin-2 deficient mice. Science 262, 1059\u20131061 (1993).","journal-title":"Science"},{"key":"BFnri1688_CR85","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0092-8674(93)80067-O","volume":"75","author":"B Sadlack","year":"1993","unstructured":"Sadlack, B., et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253\u2013261 (1993).","journal-title":"Cell"},{"key":"BFnri1688_CR86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/362245a0","volume":"362","author":"M Kopf","year":"1993","unstructured":"Kopf, M., et al. Disruption of the murine IL-4 gene blocks TH2 cytokine responses. Nature 362, 245\u2013248 (1993).","journal-title":"Nature"},{"key":"BFnri1688_CR87","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.181.4.1519","volume":"181","author":"U von Freeden-Jeffry","year":"1995","unstructured":"von Freeden-Jeffry, U. et al. Lymphopenia in interleukin-7 deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519\u20131526 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnri1688_CR88","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(00)00056-X","volume":"13","author":"JM Townsend","year":"2000","unstructured":"Townsend, J. M. et al. IL-9 deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13, 573\u2013583 (2000).","journal-title":"Immunity"},{"key":"BFnri1688_CR89","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1074-7613(00)80625-1","volume":"9","author":"GJ McKenzie","year":"1998","unstructured":"McKenzie, G. J. et al. Impaired development of TH2 cells in IL-13 deficient mice. Immunity 9, 423\u2013432 (1998).","journal-title":"Immunity"},{"key":"BFnri1688_CR90","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","volume":"3","author":"DM Willerford","year":"1995","unstructured":"Willerford, D. M. et al. Interleukin-2 receptor \u03b1 chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521\u2013530 (1995).","journal-title":"Immunity"},{"key":"BFnri1688_CR91","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1203\/00006450-200007000-00004","volume":"48","author":"CM Roifman","year":"2000","unstructured":"Roifman, C. M. Human IL-2 receptor \u03b1 chain deficiency. Pediatr. Res. 48, 6\u201311 (2000).","journal-title":"Pediatr. Res."},{"key":"BFnri1688_CR92","doi-asserted-by":"crossref","first-page":"10838","DOI":"10.1073\/pnas.94.20.10838","volume":"94","author":"N Noben-Trauth","year":"1997","unstructured":"Noben-Trauth, N. et al. An IL-4 independent pathway for CD4+ T cell IL-4 production revealed in IL-4 receptor deficient mice. Proc. Natl Acad. Sci. USA 94, 10838\u201310843 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1688_CR93","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1084\/jem.180.5.1955","volume":"180","author":"J Peschon","year":"1994","unstructured":"Peschon, J. et al. Early lymphocyte expansion is severely impaired in interleukin-7 receptor deficient mice. J. Exp. Med. 180, 1955\u20131960 (1994).","journal-title":"J. Exp. Med."}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nri1688.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri1688","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri1688.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:05:02Z","timestamp":1684861502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nri1688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":93,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9,1]]}},"alternative-id":["BFnri1688"],"URL":"https:\/\/doi.org\/10.1038\/nri1688","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,1]]},"assertion":[{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}